Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Author Correction: Smac mimetics and oncolytic viruses synergize in driving anticancer T-cell responses through complementary mechanisms.

Kim DS, Dastidar H, Zhang C, Zemp FJ, Lau K, Ernst M, Rakic A, Sikdar S, Rajwani J, Naumenko V, Balce DR, Ewanchuk BW, Tailor P, Yates RM, Jenne C, Gafuik C, Mahoney DJ.

Nat Commun. 2018 May 24;9(1):2109. doi: 10.1038/s41467-018-04597-8.

2.

Smac mimetics and oncolytic viruses synergize in driving anticancer T-cell responses through complementary mechanisms.

Kim DS, Dastidar H, Zhang C, Zemp FJ, Lau K, Ernst M, Rakic A, Sikdar S, Rajwani J, Naumenko V, Balce DR, Ewanchuk BW, Tailor P, Yates RM, Jenne C, Gafuik C, Mahoney DJ.

Nat Commun. 2017 Aug 24;8(1):344. doi: 10.1038/s41467-017-00324-x. Erratum in: Nat Commun. 2018 May 24;9(1):2109.

3.

Activation of NOTCH Signaling by Tenascin-C Promotes Growth of Human Brain Tumor-Initiating Cells.

Sarkar S, Mirzaei R, Zemp FJ, Wei W, Senger DL, Robbins SM, Yong VW.

Cancer Res. 2017 Jun 15;77(12):3231-3243. doi: 10.1158/0008-5472.CAN-16-2171. Epub 2017 Apr 17.

4.

Correction: Identification and treatment of the Staphylococcus aureus reservoir in vivo.

Surewaard BG, Deniset JF, Zemp FJ, Amrein M, Otto M, Conly J, Omri A, Yates RM, Kubes P.

J Exp Med. 2016 Dec 12;213(13):3087. Epub 2016 Nov 8. No abstract available.

5.

Identification and treatment of the Staphylococcus aureus reservoir in vivo.

Surewaard BG, Deniset JF, Zemp FJ, Amrein M, Otto M, Conly J, Omri A, Yates RM, Kubes P.

J Exp Med. 2016 Jun 27;213(7):1141-51. doi: 10.1084/jem.20160334. Epub 2016 Jun 20. Erratum in: J Exp Med. 2016 Dec 12;213(13):3087.

6.

ADAM-9 is a novel mediator of tenascin-C-stimulated invasiveness of brain tumor-initiating cells.

Sarkar S, Zemp FJ, Senger D, Robbins SM, Yong VW.

Neuro Oncol. 2015 Aug;17(8):1095-105. doi: 10.1093/neuonc/nou362. Epub 2015 Feb 1.

7.

In vitro screen of a small molecule inhibitor drug library identifies multiple compounds that synergize with oncolytic myxoma virus against human brain tumor-initiating cells.

McKenzie BA, Zemp FJ, Pisklakova A, Narendran A, McFadden G, Lun X, Kenchappa RS, Kurz EU, Forsyth PA.

Neuro Oncol. 2015 Aug;17(8):1086-94. doi: 10.1093/neuonc/nou359. Epub 2015 Jan 20.

8.

Cellular factors promoting resistance to effective treatment of glioma with oncolytic myxoma virus.

Zemp FJ, McKenzie BA, Lun X, Reilly KM, McFadden G, Yong VW, Forsyth PA.

Cancer Res. 2014 Dec 15;74(24):7260-73. doi: 10.1158/0008-5472.CAN-14-0876. Epub 2014 Oct 21.

9.

Therapeutic activation of macrophages and microglia to suppress brain tumor-initiating cells.

Sarkar S, Döring A, Zemp FJ, Silva C, Lun X, Wang X, Kelly J, Hader W, Hamilton M, Mercier P, Dunn JF, Kinniburgh D, van Rooijen N, Robbins S, Forsyth P, Cairncross G, Weiss S, Yong VW.

Ann Neurosci. 2013 Oct;20(4):154. doi: 10.5214/ans.0972.7531.200407. No abstract available.

10.

Many fences make better neighbors.

Zemp FJ, Waterhouse CC, Kubes P.

Sci Transl Med. 2014 May 21;6(237):237fs22. doi: 10.1126/scitranslmed.3009391.

PMID:
24848254
11.

Therapeutic activation of macrophages and microglia to suppress brain tumor-initiating cells.

Sarkar S, Döring A, Zemp FJ, Silva C, Lun X, Wang X, Kelly J, Hader W, Hamilton M, Mercier P, Dunn JF, Kinniburgh D, van Rooijen N, Robbins S, Forsyth P, Cairncross G, Weiss S, Yong VW.

Nat Neurosci. 2014 Jan;17(1):46-55. doi: 10.1038/nn.3597. Epub 2013 Dec 8.

PMID:
24316889
12.

Myxoma virus infection promotes NK lysis of malignant gliomas in vitro and in vivo.

Ogbomo H, Zemp FJ, Lun X, Zhang J, Stack D, Rahman MM, McFadden G, Mody CH, Forsyth PA.

PLoS One. 2013 Jun 10;8(6):e66825. doi: 10.1371/journal.pone.0066825. Print 2013.

13.

Resistance to oncolytic myxoma virus therapy in nf1(-/-)/trp53(-/-) syngeneic mouse glioma models is independent of anti-viral type-I interferon.

Zemp FJ, McKenzie BA, Lun X, Maxwell L, Reilly KM, McFadden G, Yong VW, Forsyth PA.

PLoS One. 2013 Jun 6;8(6):e65801. doi: 10.1371/journal.pone.0065801. Print 2013. Erratum in: PLoS One. 2014;9(6):e101827.

14.

Treating brain tumor-initiating cells using a combination of myxoma virus and rapamycin.

Zemp FJ, Lun X, McKenzie BA, Zhou H, Maxwell L, Sun B, Kelly JJ, Stechishin O, Luchman A, Weiss S, Cairncross JG, Hamilton MG, Rabinovich BA, Rahman MM, Mohamed MR, Smallwood S, Senger DL, Bell J, McFadden G, Forsyth PA.

Neuro Oncol. 2013 Jul;15(7):904-20. doi: 10.1093/neuonc/not035. Epub 2013 Apr 12.

15.

Neutrophils recruited to sites of infection protect from virus challenge by releasing neutrophil extracellular traps.

Jenne CN, Wong CH, Zemp FJ, McDonald B, Rahman MM, Forsyth PA, McFadden G, Kubes P.

Cell Host Microbe. 2013 Feb 13;13(2):169-80. doi: 10.1016/j.chom.2013.01.005.

16.
17.

UV-C-irradiated Arabidopsis and tobacco emit volatiles that trigger genomic instability in neighboring plants.

Yao Y, Danna CH, Zemp FJ, Titov V, Ciftci ON, Przybylski R, Ausubel FM, Kovalchuk I.

Plant Cell. 2011 Oct;23(10):3842-52. doi: 10.1105/tpc.111.089003. Epub 2011 Oct 25.

18.

The role of miRNA in the direct and indirect effects of ionizing radiation.

Dickey JS, Zemp FJ, Martin OA, Kovalchuk O.

Radiat Environ Biophys. 2011 Nov;50(4):491-9. doi: 10.1007/s00411-011-0386-5. Epub 2011 Sep 18. Review.

PMID:
21928045
19.

H2AX phosphorylation in response to DNA double-strand break formation during bystander signalling: effect of microRNA knockdown.

Dickey JS, Zemp FJ, Altamirano A, Sedelnikova OA, Bonner WM, Kovalchuk O.

Radiat Prot Dosimetry. 2011 Feb;143(2-4):264-9. doi: 10.1093/rpd/ncq470. Epub 2010 Dec 23.

20.

microRNAome changes in bystander three-dimensional human tissue models suggest priming of apoptotic pathways.

Kovalchuk O, Zemp FJ, Filkowski JN, Altamirano AM, Dickey JS, Jenkins-Baker G, Marino SA, Brenner DJ, Bonner WM, Sedelnikova OA.

Carcinogenesis. 2010 Oct;31(10):1882-8. doi: 10.1093/carcin/bgq119. Epub 2010 Jul 19.

21.

Oncolytic viruses as experimental treatments for malignant gliomas: using a scourge to treat a devil.

Zemp FJ, Corredor JC, Lun X, Muruve DA, Forsyth PA.

Cytokine Growth Factor Rev. 2010 Apr-Jun;21(2-3):103-17. doi: 10.1016/j.cytogfr.2010.04.001. Epub 2010 May 18. Review.

PMID:
20483653
22.

Small molecules with big effects: the role of the microRNAome in cancer and carcinogenesis.

Koturbash I, Zemp FJ, Pogribny I, Kovalchuk O.

Mutat Res. 2011 Jun 17;722(2):94-105. doi: 10.1016/j.mrgentox.2010.05.006. Epub 2010 May 21. Review.

PMID:
20472093
23.

Vesicular stomatitis virus oncolysis is potentiated by impairing mTORC1-dependent type I IFN production.

Alain T, Lun X, Martineau Y, Sean P, Pulendran B, Petroulakis E, Zemp FJ, Lemay CG, Roy D, Bell JC, Thomas G, Kozma SC, Forsyth PA, Costa-Mattioli M, Sonenberg N.

Proc Natl Acad Sci U S A. 2010 Jan 26;107(4):1576-81. doi: 10.1073/pnas.0912344107. Epub 2010 Jan 4.

24.

Myxoma virus virotherapy for glioma in immunocompetent animal models: optimizing administration routes and synergy with rapamycin.

Lun X, Alain T, Zemp FJ, Zhou H, Rahman MM, Hamilton MG, McFadden G, Bell J, Senger DL, Forsyth PA.

Cancer Res. 2010 Jan 15;70(2):598-608. doi: 10.1158/0008-5472.CAN-09-1510. Epub 2010 Jan 12.

25.

Altered microRNA expression patterns in irradiated hematopoietic tissues suggest a sex-specific protective mechanism.

Ilnytskyy Y, Zemp FJ, Koturbash I, Kovalchuk O.

Biochem Biophys Res Commun. 2008 Dec 5;377(1):41-5. doi: 10.1016/j.bbrc.2008.09.080. Epub 2008 Sep 26.

PMID:
18823940
26.

Sex-specific microRNAome deregulation in the shielded bystander spleen of cranially exposed mice.

Koturbash I, Zemp FJ, Kutanzi K, Luzhna L, Loree J, Kolb B, Kovalchuk O.

Cell Cycle. 2008 Jun 1;7(11):1658-67. Epub 2008 Mar 23.

PMID:
18560276
27.

Transgenerational changes in the genome stability and methylation in pathogen-infected plants: (virus-induced plant genome instability).

Boyko A, Kathiria P, Zemp FJ, Yao Y, Pogribny I, Kovalchuk I.

Nucleic Acids Res. 2007;35(5):1714-25. Epub 2007 Feb 20.

Supplemental Content

Support Center